During the past decade, Klinik für Dermatologie, Venerologie und Allergologie, Charité-Universitätsmedizin conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 6 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinik für Dermatologie, Venerologie und Allergologie, Charité-Universitätsmedizin" #1 sponsor was "Charite University, Berlin, Germany" with 2 trials, followed by "Follicum AB" with 2 trials sponsored, "Galderma R&D" with 2 trials sponsored, "LEO Pharma" with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinik für Dermatologie, Venerologie und Allergologie, Charité-Universitätsmedizin" #1 collaborator was "Bioskin GmbH" with 1 trials as a collaborator, "LEO Pharma" with 1 trials as a collaborator and "Sanofi" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Klinik für Dermatologie, Venerologie und Allergologie, Charité-Universitätsmedizin" are "Psoriasis" (4 trials), "Atopic Dermatitis" (3 trials), "Alopecia" (1 trials), "Androgenic Alopecia" (1 trials) and "Dermatomyositis" (1 trials). Many other conditions were trialed in "Klinik für Dermatologie, Venerologie und Allergologie, Charité-Universitätsmedizin" in a lesser frequency.

Most popular intervention types in "Klinik für Dermatologie, Venerologie und Allergologie, Charité-Universitätsmedizin" are "Drug" (13 trials), "Other" (4 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Cromoglicate" (2 trials), "FOL-005" (2 trials), "not applicable, observational study" (2 trials) and "ABP 654" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinik für Dermatologie, Venerologie und Allergologie, Charité-Universitätsmedizin" are 14 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Klinik für Dermatologie, Venerologie und Allergologie, Charité-Universitätsmedizin". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Klinik für Dermatologie, Venerologie und Allergologie, Charité-Universitätsmedizin, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Klinik für Dermatologie, Venerologie und Allergologie, Charité-Universitätsmedizin, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".